Motion sickness susceptibility questionnaire revised and its relationship to other forms of sickness JF Golding Brain research bulletin 47 (5), 507-516, 1998 | 633 | 1998 |
Motion sickness susceptibility JF Golding Autonomic Neuroscience 129 (1-2), 67-76, 2006 | 490 | 2006 |
Predicting individual differences in motion sickness susceptibility by questionnaire JF Golding Personality and Individual differences 41 (2), 237-248, 2006 | 457 | 2006 |
The effects of economic circumstances on British students' mental and physical health R Roberts, J Golding, T Towell, I Weinreb Journal of American College Health 48 (3), 103-109, 1999 | 360 | 1999 |
[18F] 2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours … RE Ferner, JF Golding, M Smith, E Calonje, W Jan, V Sanjayanathan, ... Annals of Oncology 19 (2), 390-394, 2008 | 290 | 2008 |
Visual dependency and dizziness after vestibular neuritis S Cousins, NJ Cutfield, D Kaski, A Palla, BM Seemungal, JF Golding, ... PloS one 9 (9), e105426, 2014 | 201 | 2014 |
Mental and physical health in students: the role of economic circumstances R Roberts, J Golding, T Towell, S Reid, S Woodford, A Vetere, I Weinreb British Journal of Health Psychology 5 (3), 289-297, 2000 | 195 | 2000 |
Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial M Patel, K Agarwal, Q Arshad, M Hariri, P Rea, BM Seemungal, ... The Lancet 388 (10061), 2753-2762, 2016 | 187 | 2016 |
Motion sickness susceptibility in healthy subjects and vestibular patients: effects of gender, age and trait-anxiety AC Paillard, G Quarck, F Paolino, P Denise, M Paolino, JF Golding, ... Journal of Vestibular Research 23 (4-5), 203-209, 2013 | 187 | 2013 |
A motion sickness maximum around the 0.2 Hz frequency range of horizontal translational oscillation JF Golding, AG Mueller, MA Gresty Aviation, space, and environmental medicine 72 (3), 188-192, 2001 | 150 | 2001 |
Pathophysiology and treatment of motion sickness JF Golding, MA Gresty Current opinion in neurology 28 (1), 83-88, 2015 | 146 | 2015 |
Motion sickness JF Golding Handbook of clinical neurology 137, 371-390, 2016 | 142 | 2016 |
Predictors of clinical recovery from vestibular neuritis: a prospective study S Cousins, D Kaski, N Cutfield, Q Arshad, H Ahmad, MA Gresty, ... Annals of clinical and translational neurology 4 (5), 340-346, 2017 | 140 | 2017 |
The social impact of dizziness in London and Siena AM Bronstein, JF Golding, MA Gresty, M Mandalà, D Nuti, A Shetye, ... Journal of neurology 257, 183-190, 2010 | 133 | 2010 |
Increasing cognitive load with increasing balance challenge: recipe for catastrophe J Barra, A Bray, V Sahni, JF Golding, MA Gresty Experimental brain research 174, 734-745, 2006 | 132 | 2006 |
The psychopharmacology of smoking JF Golding Cambridge University Press, 1984 | 125 | 1984 |
A comparison of the nauseogenic potential of low-frequency vertical versus horizontal linear oscillation. JF Golding, M Kerguelen Aviation, space, and environmental medicine 63 (6), 491-497, 1992 | 120 | 1992 |
Motion sickness JF Golding, MA Gresty Current opinion in neurology 18 (1), 29-34, 2005 | 118 | 2005 |
Arousing and de‐arousing effects of cigarette smoking under conditions of stress and mild sensory isolation J Golding, GL Mangan Psychophysiology 19 (4), 449-456, 1982 | 115 | 1982 |
Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate JF Golding, JRR Stott British journal of clinical pharmacology 43 (6), 633-637, 1997 | 113 | 1997 |